Uterine Cancer Medical Malpractice Lawyer Compensation Claims



Legal Helpline 855-804-7142



Thousands of Canadian citizens are diagnosed with uterine cancer every year. The key to survival is early diagnosis and treatment which is often delayed due to misdiagnosis or misinterpreted test results. Uterine cancer misdiagnosis is extremely common and failure by a healthcare practitioner that amounts to negligence is a matter of medical malpractice and entitles the victim to claim financial recompense for pain and suffering or the loss of opportunity for a cure. Our specialist medical malpractice lawyers deal with uterine cancer clinical negligence cases against doctors, nurses, technicians and other healthcare providers working in medical practices, clinics, hospitals and all other places where health care is dispensed. If you would like advice about uterine cancer misdiagnosis just contact our offices and a specialist medical malpractice lawyer with call to discuss your potential compensation claim without charge and without further obligation. Our medical malpractice lawyers will give you their opinion on the liability of the negligent healthcare provider and will estimate the amount of the likely award of damages there and then.

Uterine Cancer Misdiagnosis Facts

About 4,000 women will be diagnosed with uterine cancer or cancer of the endometrium in Canada per year. Of these, about 800 will die of the disease per year. Uterine cancer can be an endometrial cancer or a uterine sarcoma. Only about 2 percent of cancers of the uterus are sarcomas, which are uterine muscle tumors. Endometrial cancer is cancer of the lining of the uterus.

Endometrial cancer rarely shows up in women under the age of forty years. More than half of all women with endometrial cancer are diagnosed between the ages of 50 and 69. This amounts to an average lifetime chance of getting endometrial cancer of one in 40. Endometrial cancer is more common in whites; however, more black women die from the disease. It is the fourth most common cancer in women and the eighth most common cause of death due to cancer for women in North America.

Ninety two percent of women with uterine cancer live to be one year free of cancer. The five year survival rate is 96 percent overall. If the cancer has regionally spread, the survival rate drops to about 67 percent. Those identified with metastatic disease have a five year survival rate of around 17 percent.

Things that increase the risk of uterine cancer include increased estrogen levels, such as with estrogen replacement therapy postmenopausally. Other risk factors include diabetes, unopposed estrogen, infertility or not choosing to have children, having infrequent periods, taking Tamoxifen for breast cancer therapy, obesity, having polycystic ovarian syndrome, having late menopause or early menarche (the start of one’s periods). Endometrial cancer seems also to be linked to getting colon cancer, breast cancer, gallbladder disease, polycystic ovarian disease and high blood pressure.

The main symptoms of endometrial cancer include having abnormal periods or abnormal uterine bleeding, especially if it is after menopause. If you have extensive periods after the age of 40, you may have endometrial cancer. If you have pelvic cramping or lower abdominal pain, you are at risk for uterine cancer and if you notice significant clear or white discharge after menopause, it may be a symptom of endometrial cancer.

Doctors diagnose uterine cancer by doing an endometrial aspiration or biopsy by inserting a curette and getting a tissue sampling. If this is negative, a dilatation and curettage is performed which scrapes off nearly all the endometrium before the doctor looks at the tissue under the microscope. In some cases, a pap smear can show evidence for endometrial cancer but is not a diagnostic test for the disease.

If cancer is detected on the above tests, the doctor needs to determine the stage of the disease. Staging determines what kind of treatment is necessary. Stage I disease is well confined to the uterine lining and uterus; stage II disease means the cancer has spread to the cervix as well as the uterus; stage III disease means the cancer has spread outside the uterus but not outside the pelvic structures; stage IV disease means the cancer has spread to the bowel, bladder, other abdominal areas and distant areas. Endometrial cancer is also graded, meaning that there are different degrees of aggressiveness to the cells of the cancer.

Doctors can do a laparoscopy, CT scan or MRI scan to see whether or not the disease has spread to other body areas.

The treatment of endometrial cancer involves surgery, radiation therapy and sometimes chemotherapy. Women almost always have a hysterectomy along with removal of the ovaries and tubes. This is curative in stage I cancer. It is recommended that the patient have an abdominal hysterectomy so the doctor can look at and sample lymph nodes and can look at other possible areas of involvement.

Radiation is used for stage I or II disease to get rid of any residual active tumor. Chemotherapy is reserved for stage III and IV endometrial cancer.

Legal Helpline 855-804-7142